Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length

View ORCID ProfileClaire F. McGroder, David Zhang, Mohammad A. Choudhury, Mary M. Salvatore, Belinda M. D’Souza, Eric A. Hoffman, Ying Wei, View ORCID ProfileMatthew R. Baldwin, Christine Kim Garcia
doi: https://doi.org/10.1101/2021.03.17.21253834
Claire F. McGroder
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claire F. McGroder
David Zhang
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad A. Choudhury
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary M. Salvatore
2Department of Radiology, Columbia University Irving Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belinda M. D’Souza
2Department of Radiology, Columbia University Irving Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric A. Hoffman
3Deparment of Radiology, University of Iowa Carver College of Medicine, Iowa City, Iowa
4Department of Internal Medicine, and University of Iowa Carver College of Medicine, Iowa City, Iowa
5Department of Biomedical Engineering, University of Iowa Carver College of Medicine, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Wei
6Department of Biostatistics, Columbia University Irving Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew R. Baldwin
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew R. Baldwin
Christine Kim Garcia
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
7Institute of Genomic Medicine, Columbia University Irving Medical Center
8Center for Precision Medicine and Genomics, Columbia University Irving Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ckg2116{at}cumc.columbia.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The risk factors for development of fibrotic interstitial lung abnormalities (ILA) after severe COVID-19 are incompletely described and the extent to which CT findings correlate with symptoms and physical function after hospitalization remain unclear. At 4 months after hospitalization, fibrotic ILA was more common in those who underwent mechanical ventilation (72%) than in those who did not (20%). We demonstrate that severity of initial illness, duration of mechanical ventilation, lactate dehydrogenase on admission, and leukocyte telomere length are independent risk factors for fibrotic ILA. These fibrotic changes correlate with lung function, cough and measures of frailty, but not with dyspnea.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by grants from the NIH (R01HL103676, R01HL093096 to CKG; T32HL105323 to CM; UL1TR001873 to MRB) and the Department of Defense (PR202907 to CKG and MRB).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Columbia University Irving Medical Center (CUIMC) Institutional Review Board study protocol number is AAAR1916.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials. Raw data were generated at Columbia University Medical Center. Derived data supporting the findings of this study are available from the corresponding author [CG] on request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted March 20, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length
Claire F. McGroder, David Zhang, Mohammad A. Choudhury, Mary M. Salvatore, Belinda M. D’Souza, Eric A. Hoffman, Ying Wei, Matthew R. Baldwin, Christine Kim Garcia
medRxiv 2021.03.17.21253834; doi: https://doi.org/10.1101/2021.03.17.21253834
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length
Claire F. McGroder, David Zhang, Mohammad A. Choudhury, Mary M. Salvatore, Belinda M. D’Souza, Eric A. Hoffman, Ying Wei, Matthew R. Baldwin, Christine Kim Garcia
medRxiv 2021.03.17.21253834; doi: https://doi.org/10.1101/2021.03.17.21253834

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)